Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

905
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
905
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schizophrenia in Offspring of Holocaust Survivors: Intergenerational Effects of Preconception Parental Trauma Within the Jerusalem Perinatal Study.

The American journal of psychiatry·2026
Same author

Near-infrared OCT imaging for the assessment of anisocoria.

Eye (London, England)·2026
Same author

Pathways-to-Care Analysis of Non-Hodgkin Lymphoma in Ethiopia: A Mixed-Methods Study.

JCO global oncology·2026
Same author

Hot flashes linked to linguistic markers of cognitive impairment: observational study of social media posts.

Menopause (New York, N.Y.)·2025
Same author

Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study.

The Lancet. Infectious diseases·2025
Same author

Occupational, Lifestyle, and Medical Risk Factors for Non-Hodgkin Lymphoma: A Case-Control Study in Ethiopia.

Cancers·2025
Same journal

Effects of Add-On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial.

Annals of clinical and translational neurology·2026
Same journal

Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same journal

A 57-Year-Old Male With Behavioral Variant Frontotemporal Dementia and MATR3 and NOS3 Mutations.

Annals of clinical and translational neurology·2026
Same journal

Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026
Same journal

A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome.

Annals of clinical and translational neurology·2026
Same journal

Long-Term Neurologic Exam Findings in People Diagnosed and Treated During Acute HIV Infection.

Annals of clinical and translational neurology·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

A machine learning algorithm successfully screens for Parkinson's in web users.

Brit Youngmann1, Liron Allerhand1, Ora Paltiel2

  • 1Microsoft Research, Herzliya, Israel.

Annals of Clinical and Translational Neurology
|November 13, 2019
PubMed
Summary
This summary is machine-generated.

A new web-based tool screens for Parkinson disease using search engine behavior. It identifies individuals at higher risk and shows faster disease progression, raising ethical considerations.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.2K

Related Experiment Videos

Last Updated: Jan 4, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.2K

Area of Science:

  • Neurology
  • Computer Science
  • Public Health

Background:

  • Parkinson disease (PD) diagnosis can be challenging and often occurs late.
  • Early detection and monitoring are crucial for managing PD progression.
  • Leveraging digital footprints for health screening is an emerging area.

Purpose of the Study:

  • To develop and evaluate a novel web-based classifier for screening Parkinson disease (PD) in a large cohort of search engine users.
  • To assess the classifier's ability to identify individuals at risk for PD based on their online behavior.
  • To investigate disease progression in individuals screened positive for PD.

Main Methods:

  • A supervised machine learning classifier was trained using search engine interaction data (mouse and keyboard movements) to distinguish users with self-reported PD from controls.
  • The classifier was applied to a large cohort of web users over 40 years old.
  • Web query content was used to categorize users into risk groups but not for classification; disease detection was unsolicited and anonymized.

Main Results:

  • The classifier identified 1.2% (17,843/1,490,987) of users over 40 as potentially having PD.
  • Screen-positive rates were significantly higher in at-risk groups, including those searching for PD information (64.4%) or with non-motor symptoms/affected relatives (5.3%).
  • Individuals classified as having PD showed a higher mean rate of progression in disease-related features during longitudinal follow-up.

Conclusions:

  • An automated classifier using search engine interactions can reliably identify individuals at high risk for Parkinson disease.
  • The classifier demonstrated a higher rate of disease progression in positive cases, suggesting its utility for monitoring.
  • The findings highlight the potential of digital tools for unsolicited disease screening and raise important ethical considerations.